Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Critical Path Institute Stories

2014-02-04 12:27:12

Multi-year grant brings together non-profits, government, academia and the pharmaceutical industry to study pressing public health challenge TUCSON, Ariz., Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute, an independent, non-profit that catalyzes innovative ideas that accelerate the speed of drug and medical product development, today announced it has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop...

2014-02-03 12:28:31

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Companion Biomarkers in Drug Development Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to...

2014-01-29 12:27:40

CFAST Develops Processes to Accelerate Understanding of Alzheimer's disease and Asthma AUSTIN, Texas, Jan. 29, 2014 /PRNewswire-USNewswire/ -- The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. ("TransCelerate") announced today that version 1.0 of the Asthma Therapeutic Area (TA) User Guide (UG) and version 2.0 of the Alzheimer's TAUG are now available for implementers on the CDISC website. These user guides...

2014-01-13 00:22:35

The NBDA Intends to Change the Dismal Success Rate of Biomarkers by Creating Evidence Based, End-to-End Biomarker Development Processes A Collaborative Network-Based, Non-Profit Organization, the NBDA Will Create Standards to Successfully Develop Biomarkers Needed for Precision (personalized) Medicine WASHINGTON, Jan. 13, 2014 /PRNewswire-USNewswire/ -- The launch of a new independent, non-profit organization, the National Biomarker Development Alliance (NBDA), broadly engaging...

2013-12-18 08:28:24

KONTICH, Belgium, December 18, 2013 /PRNewswire/ -- FLUIDDA develops proprietary Functional Respiratory Imaging (FRI) technology that provides a unique entry point into personalized medicine for respiratory diseases. FRI reduces significantly the number of patients needed in clinical trials, resulting in better drugs coming to the market faster. FLUIDDA is invited by the FDA to present the benefits of this unique technology for the screening of new respiratory drugs....

2013-11-07 23:26:02

Development of Standards Aid FDA in Meeting Commitments under PDUFA V Tucson, AZ (PRWEB) November 07, 2013 The FDA has awarded a two-year, $2 million grant to Critical Path Institute for its joint initiative with the Clinical Data Interchange Standards Consortium (CDISC) to strengthen the framework and further the objectives of the Coalition for Accelerating Standards and Therapies, known as CFAST. The grant comes as part of FDA efforts to support the development of new data standards...

2013-09-18 08:30:48

AUSTIN, Texas, Sept. 18, 2013 /PRNewswire/ -- The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma Inc. ("TransCelerate"), are pleased to announce that version 1.0 of the Asthma Therapeutic Area (TA) Data Standard is now available for public review on the CDISC website. The Asthma TA standard is the first standard to have been developed with TransCelerate's active participation in the Coalition for Accelerating Standards and Therapies (CFAST)...

2013-04-17 23:03:46

Critical Path Institute´s (C-Path) Polycystic Kidney Disease Outcomes Consortium (PKDOC) (http://www.c-path.org/pkd.cfm) , the Clinical Data Interchange Standards Consortium (CDISC), and the PKD Foundation announced today the launch of version 1.0 of the Polycystic Kidney Disease (PKD) Therapeutic Area User Guide, a clinical data standard that provides guidance on the implementation of the CDISC Study Data Tabulation Model (SDTM) to represent PKD data in regulatory submissions. Tucson,...

2012-12-06 16:23:59

The partners work together to accelerate development of new treatments for multiple sclerosis NEW YORK, CLEVELAND and TUCSON, Ariz., Dec. 6, 2012 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society and Critical Path Institute (C-Path) announced today that they have joined forces to launch the Multiple Sclerosis Outcome Assessments Consortium (MSOAC). This coalition of industry, academia, patient representatives, regulatory agencies, and the National MS Society will...

2012-09-13 23:01:14

The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the launch of the Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year. The official launch of CFAST will take place at the CDISC 2012 International Interchange in Baltimore, Maryland (24-26 October 2012). Austin, TX (PRWEB) September 12, 2012 The Clinical Data Interchange Standards Consortium (CDISC) and Critical...